ChiCTR2000034028 版本V1.1 版本创建时间2020/06/21 13:51:54 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000034028 

最近更新日期:

Date of Last Refreshed on:

2020-06-21 13:51:20 

注册时间:

Date of Registration:

1990-01-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

食管裂孔疝完全左侧手术入路与传统手术入路的近远期疗效及安全性的临床研究

Public title:

Clinical study on the short-term and long-term efficacy and safety of esophageal hiatal hernia with complete left-side surgical approach and traditional surgical approach

注册题目简写:

English Acronym:

研究课题的正式科学名称:

食管裂孔疝完全左侧手术入路与传统手术入路的近远期疗效及安全性的临床研究

Scientific title:

Clinical study on the short-term and long-term efficacy and safety of esophageal hiatal hernia with complete left-side surgical approach and traditional surgical approach

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

郑智 

研究负责人:

尹杰 

Applicant:

Zhengzhi 

Study leader:

Yin jie 

申请注册联系人电话:

Applicant telephone:

18311002896

研究负责人电话:

Study leader's telephone:

15011302788

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

z.z1003@163.com

研究负责人电子邮件:

Study leader's E-mail:

yj232325@sina.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市西城区永安路95号

研究负责人通讯地址:

北京市西城区永安路95号

Applicant address:

95-Yongan Road, Xicheng District, Beijing

Study leader's address:

95-Yongan Road, Xicheng District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京友谊医院

Applicant's institution:

Beijing Friendship Hospital

研究负责人所在单位:

北京友谊医院

Affiliation of the Leader:

Beijing Friendship Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

L-2020-019

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

首都医科大学附属北京友谊医院生命伦理委员会

Name of the ethic committee:

Bioethics Committee of Beijing Friendship Hospital, Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-05-22 00:00:00

伦理委员会联系人:

崔琰

Contact Name of the ethic committee:

cuiyan

伦理委员会联系地址:

北京市西城区永安路95号

Contact Address of the ethic committee:

95-Yongan Road, Xicheng District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京友谊医院

Primary sponsor:

Beijing Friendship Hospital

研究实施负责(组长)单位地址:

北京市西城区永安路95号

Primary sponsor's address:

95-Yongan Road, Xicheng District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京友谊医院

具体地址:

西城区永安路95号

Institution
hospital:

Beijing Friendship Hospital

Address:

95 Yong'an Road, Xicheng District

经费或物资来源:

自筹

Source(s) of funding:

self-finance

Target disease:

Hiatal hernia

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究旨在通过对食管裂孔疝采用完全左侧手术入路与传统手术入路(即双侧手术入路)进行优效性、随机对照研究,比较两种不同手术方式对于食管裂孔疝患者近、远期疗效和围手术期安全性的影响,最大程度进行器官功能和神经的保护,降低并发症的发生,提高患者生活质量,为规范食管裂孔疝的外科治疗提供证据支持。  

Objectives of Study:

The purpose of this study is to conduct a superior, randomized controlled study on the complete left-side surgical approach and traditional surgical approach (ie, bilateral surgical approach) for esophageal hiatal hernia, and compare the two different surgical methods for patients with esophageal hiatal hernia. , The long-term efficacy and the impact of perioperative safety, maximize the protection of organ function and nerves, reduce the occurrence of complications, improve the quality of life of patients, and provide evidence support for the standardization of surgical treatment of esophageal hiatal hernia.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①经胃镜及食管高分辨测压、24小时食管pH检测、上消化道造影、腹部CT检查均支持食管裂孔疝(II\III\IV型)伴有GERD;
②患者有反流、反酸、胸前区烧灼痛等返流症状,且经过规律的内科保守治疗症状无明显好转;
③年龄18-75岁,无论性别,体力评分ECOG≤2分,ASA评分≤2分,可耐手术治疗,肝、肾、骨髓功能正常;
④能够遵守研究期间的方案,并签署知情同意书;
⑤患者愿意接受随访并配合专职人员做好相关记录;
⑥无胃肠道手术史、恶性肿瘤病史、无化疗或放疗史。

Inclusion criteria

①Through gastroscopy and high-resolution esophageal manometry, 24-hour esophageal pH test, upper gastrointestinal angiography, and abdominal CT examination support esophageal hiatal hernia (type II\III\IV) with GERD;
②The patient has reflux symptoms such as reflux, acid reflux, and burning pain in the chest area, and the symptoms have not improved significantly after regular medical conservative treatment;
③Age 18-75 years old, regardless of gender, physical performance score ECOG ≤ 2 points, ASA score ≤ 2 points, resistant to surgical treatment, normal liver, kidney and bone marrow function;
④ Ability to abide by the plan during the study and sign an informed consent;
⑤ The patient is willing to follow up and cooperate with the full-time staff to make relevant records;
⑥ No history of gastrointestinal surgery, malignant tumor history, no history of chemotherapy or radiotherapy.

排除标准:

①合并严重心肺疾病且对手术无法耐受的患者;
②不愿意承担手术风险,未能签署手术知情同意书的患者;
③不能控制的内科疾病(包括6个月内出现的不稳定心绞痛、心肌梗塞、脑血管意外);
④因全身其他脏器情况不能接受全麻或手术治疗;
⑤有未控制的癫痫、中枢神经系统疾病或精神障碍史者;
⑥器官移植需要免疫抑制治疗者;
⑦严重的未控制的反复感染者,或其它严重的未控制的伴随疾病;
⑧持续全身类固醇激素治疗;
⑨妊娠或哺乳期妇女育龄妇女;
⑩同时参加其它临床试验。

Exclusion criteria:

① Patients with severe cardiopulmonary disease and intolerance to surgery;
②Patients who are unwilling to bear the risk of surgery and fail to sign the informed consent for surgery;
③ Uncontrollable medical diseases (including unstable angina pectoris, myocardial infarction, cerebrovascular accident within 6 months);
④Cannot receive general anesthesia or surgical treatment due to other organs in the whole body;
⑤Have a history of uncontrolled epilepsy, central nervous system diseases or mental disorders;
⑥ Those who need immunosuppressive treatment for organ transplantation;
⑦Severe uncontrolled repeated infections, or other serious uncontrolled concomitant diseases;
⑧Continuous systemic steroid hormone treatment;
⑨Pregnant or breastfeeding women of childbearing age;
⑩ Participate in other clinical trials at the same time.

研究实施时间:

Study execute time:

From 2021-01-01 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-01-01 00:00:00 To 2023-11-30 00:00:00  

干预措施:

Interventions:

组别:

试验组

样本量:

57

Group:

Experimental Group

Sample size:

干预措施:

完全左侧手术入路

干预措施代码:

Intervention:

Complete left surgical approach

Intervention code:

组别:

对照组

样本量:

57

Group:

Control Group

Sample size:

干预措施:

传统手术路

干预措施代码:

Intervention:

Traditional Surgical approach

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China 

Province:

Beijing 

City:

 

单位(医院):

北京友谊医院 

单位级别:

三级甲等 

Institution
hospital:

Beijing Friendship Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

GLQI生活质量评分

指标类型:

主要指标

Outcome:

GLQI life quality score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

胆囊结石发生率

指标类型:

次要指标

Outcome:

Incidence of gallstone

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

胃排空障碍发生率

指标类型:

次要指标

Outcome:

Incidence of gastric emptying disorders

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

为保证受试者组间临床资料的匹配,本研究采用区组随机法将受试者随机分配至试验组和对照组。试验组采用腹腔镜完全左侧手术入路;对照组采用腹腔镜传统手术入路(即双侧入路)。随机化过程采用随机数字表进行,本中心人员记录并填写如下信息后进行分组。 ①患者姓名汉语拼音首字母、住院号、登记号 ②是否采用完全左侧入路进行手术(是/否)

Randomization Procedure (please state who generates the random number sequence and by what method):

In order to ensure the matching of clinical data between the subject groups, this study used the block randomization method to randomly assign the subjects to the test group and the control group. The experimental group used laparoscopic complete left surgical approach; the control group used laparoscopic tradi

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

None

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-06-21 13:51:16